Home › Funds › Sensenig Capital Advisors, Inc › LLY

Sensenig Capital Advisors, Inc position in LLY

ELI LILLY & CO · Health Care

Sensenig Capital Advisors, Inc reported holding 177 shares of LLY (ELI LILLY & CO) in its Q2 2026 13F filing — a position valued at US$212K, representing 0.19% of its reported portfolio and ranking #33 among its reported holdings. Sensenig Capital Advisors, Inc has disclosed LLY holdings in 2 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)177 sh
Reported value held$212.30K
Portfolio Weight0.19%
First reportedQ4 2025
Last changeNew
Updated2026-10-24

How Sensenig Capital Advisors, Inc's LLY position evolved

Sensenig Capital Advisors, Inc first disclosed a stake in LLY in Q4 2025 at 238 shares (US$256K). Across 2 filings, Sensenig Capital Advisors, Inc held the position steady without any share-count change. The most recent filing (Q2 2026) shows 177 shares valued at US$212K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 238 $255.77K New
Q2 2026 177 $212.30K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (ELI LILLY & CO) is a Health Care company. 38 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →